Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessneuronal stem cell population maintenance

FANCC WDR47

6.83e-0526102GO:0097150
GeneOntologyBiologicalProcesscorpus callosum development

DMXL2 WDR47

1.11e-0433102GO:0022038
DomainWD40

DMXL2 WDR47

9.70e-03259112PF00400
DomainWD40

DMXL2 WDR47

1.04e-02268112SM00320
DomainWD40_repeat

DMXL2 WDR47

1.07e-02272112IPR001680
DomainWD_REPEATS_1

DMXL2 WDR47

1.11e-02278112PS00678
DomainWD_REPEATS_2

DMXL2 WDR47

1.12e-02279112PS50082
DomainWD_REPEATS_REGION

DMXL2 WDR47

1.12e-02279112PS50294
DomainWD40_repeat_dom

DMXL2 WDR47

1.26e-02297112IPR017986
Domain-

DMXL2 WDR47

1.57e-023331122.130.10.10
DomainWD40/YVTN_repeat-like_dom

DMXL2 WDR47

1.59e-02335112IPR015943
Pubmed

WD40-repeat 47, a microtubule-associated protein, is essential for brain development and autophagy.

DMXL2 WDR47

7.05e-054011229078390
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

DMXL2 ZNFX1 SPARCL1 WDR47

3.14e-04113911436417873
InteractionDSCR9 interactions

ZNFX1 SPARCL1 WDR47

6.01e-05147113int:DSCR9
CytobandEnsembl 112 genes in cytogenetic band chr17p13

VPS53 NLRP1

2.98e-03346112chr17p13
GeneFamilyWD repeat domain containing

DMXL2 WDR47

8.72e-03262102362
CoexpressionGSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP

TRPM6 SPARCL1 VPS53

6.50e-05196113M9867
CoexpressionPEREZ_TP53_TARGETS

ZNFX1 TRPM6 MUC5AC NLRP1 WDR47

7.34e-051201115M4391
ToppCellEndothelial-Endothelial-F|Endothelial / shred on cell class and cell subclass (v4)

ZNFX1 SPARCL1

3.95e-041221122cb8bb63c69aed4d4504b9d97219b8707666f950
ToppCellTCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9

MUC5AC VPS53

6.52e-041571125fb41af247465aa29aa7b8edd26e3d3794766f80
ToppCellRV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

SPARCL1 LPP

6.77e-0416011229c9b4770d0e73d59cffc7937b179484c76b6dcc
ToppCellRV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper

SPARCL1 LPP

6.85e-0416111247b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

7.02e-04163112e526104a3a574ee860078ce7c049e7fec9443f37
ToppCellfacs-Limb_Muscle-forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPARCL1 MUC5AC

7.19e-04165112f80665b75d43f1bf6919d59fc762e7e0bac653f2
ToppCellLV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

SPARCL1 LPP

7.19e-04165112f37fd95adc95d7753cf6e55ae819976513c7ec77
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 NLRP1

7.28e-04166112ec719368295133da2f7ff587c5329ed6db1dd56d
ToppCellChildren_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

TRPM6 SPARCL1

7.37e-04167112d7fe24cdc4b55a9555ce9e20699f5036b88148e9
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPARCL1 LPP

7.54e-04169112a6a5b00912b653fad2ca7f096deaf35c9ef85e5b
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPARCL1 LPP

7.54e-0416911242a9b8c77d2a4d68b01e4db38f8a1af53c9c814f
ToppCellPND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPARCL1 LPP

7.54e-0416911288aa2246ede582c2e11de63228d76f520889ecb3
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPARCL1 LPP

7.63e-04170112cb1ed6bd409ee1cf11be0d5e7cdcffe2ab220d38
ToppCellPND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPARCL1 LPP

7.63e-04170112da4fb1e186e9bec6bba0b25f2a0e68f9e11c6017
ToppCelldroplet-Thymus-nan-21m-Lymphocytic-Macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NLRP1 WDR47

7.72e-04171112a474aaed3ca4cacb0ab565c35f25d92a10f531b7
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

7.72e-04171112fe0665c5ca01b0b2cc8f20d64587f0847c3d215c
ToppCellLV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper

SPARCL1 LPP

7.72e-04171112e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

SPARCL1 LPP

7.90e-04173112cb6389536195443633adb06e5f1b7483530773d1
ToppCellkidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 LPP

7.90e-04173112fc2602b2ce051cd4c33957d7e3d041ff8a529883
ToppCellkidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 LPP

7.90e-04173112901b8e6909c1f3849906fad9cee17b8f0bab050d
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPARCL1 LPP

7.99e-041741127fb7bdf62563f2102fb38618b503eb2817b6594f
ToppCellPND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DMXL2 NLRP1

7.99e-0417411265147b0f8c2ccadd5685430d31081520c157536a
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TRPM6 MUC5AC

7.99e-0417411242f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TRPM6 MUC5AC

7.99e-041741123f0a5ce074675d57d479fa069385a1b3071e884e
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SPARCL1 MUC5AC

8.09e-04175112dc7721794162dee96944f4b4b87b5681bb02ea8f
ToppCellCOVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type

SPARCL1 LPP

8.09e-041751121125f0d3a5b2388fa77a820dea0288e824d84a82
ToppCelldroplet-Liver-LIVER-NPC-1m-Endothelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FANCC VPS53

8.09e-0417511298dc3b6f69a29d587f503898f09912700950e3d9
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 LPP

8.27e-04177112a8625d14682183cf77cb51eaf11bc15a3528f586
ToppCellLPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DMXL2 NLRP1

8.27e-04177112cdad5a2f672a7f07c05669bfcaf1ec74defd3de7
ToppCellLPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DMXL2 NLRP1

8.27e-04177112991ae76bb615392d84aeb89886148fa42c1c649c
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 LPP

8.27e-041771123645e2f4a48283f290f85c49c3e79e3f58ac9aa6
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 NLRP1

8.36e-041781125f779a66aa42d1d8e8af17b4a08d5dcc733efd4c
ToppCellLPS_only-Myeloid-Monocytes,_Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DMXL2 NLRP1

8.46e-04179112330c1326ba93bb8f32559ee1cc40e357cc44ad8d
ToppCellCOVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type

SPARCL1 LPP

8.46e-04179112a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCellLPS_only-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DMXL2 NLRP1

8.46e-04179112dc03b9045510eb1bb934329646bb92dd06890ce9
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DMXL2 NLRP1

8.55e-0418011297241f62ee133dcb0d4855ffda5dd1349de9f7b2
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DMXL2 NLRP1

8.55e-0418011241896546cd1cc458e08c0d4e19aa4860e5d4fcd6
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SPARCL1 LPP

8.64e-04181112eea943fdcbef0bbaa8578f3296923e874893b405
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SPARCL1 LPP

8.64e-041811129c157de9d3403e092c907599f2a2c16db5b21131
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

8.64e-04181112beb2771820956be8b190c0088ae3c4efdb53c897
ToppCellRA-07._Pericyte|RA / Chamber and Cluster_Paper

SPARCL1 LPP

8.64e-041811128dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCellRA-07._Pericyte|World / Chamber and Cluster_Paper

SPARCL1 LPP

8.74e-041821122075efeae633550fb2eb026d0dfd741c8252482e
ToppCell5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZNFX1 SPARCL1

8.74e-0418211252274af3136d4fd4a495f5882618444661421f0f
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DMXL2 NLRP1

8.74e-041821120b59ead4bb4486c7ec2ee90b94ee3a09905612c5
ToppCell3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

8.74e-04182112728a2152c166551ac229370c0900fe2bc426ea9b
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

8.74e-041821127b86703559438e2d5ef3dad963ee0d772513f313
ToppCell5'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZNFX1 SPARCL1

8.74e-04182112dfde2d9950f445c6c936ac828f7210de87bb45ec
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

DMXL2 NLRP1

8.74e-04182112d5d6bc16458bc665e7ad6669040d79f73f640044
ToppCellRA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper

SPARCL1 LPP

8.83e-04183112818fd886e0188091310825f9145fa53328f2c979
ToppCellLA-07._Pericyte|World / Chamber and Cluster_Paper

SPARCL1 LPP

8.83e-04183112e3835db4795362b0442d5893baf2a78efcc20428
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM6 SPARCL1

8.83e-041831124759560e5b4f4e5a00e5f933e3451a27c7c4aefe
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRPM6 SPARCL1

8.83e-04183112dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed
ToppCelldroplet-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FANCC SPARCL1

8.83e-04183112ddc45fb591ba0ce3fa05c08051d58286a89ef835
ToppCell5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SPARCL1 LPP

8.83e-04183112bc7dd6a40ec9c773d005c1a46f305d40cdd0a326
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

8.83e-041831126b5eef96b28911c752a8b6c0975918c4572cec38
ToppCelldroplet-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FANCC SPARCL1

8.83e-04183112a253ad65673fce6cb453e709cb235ce7cbfa18b7
ToppCellRA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper

SPARCL1 LPP

8.83e-04183112cae2ee08f985a6f005b4b8e959e465350315156a
ToppCell3'-Child09-12-SmallIntestine-Mesenchymal-myocytic|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

8.93e-041841125cfc19ffb9f074bdf0d81c86e212a708ec141631
ToppCellLA-07._Pericyte|LA / Chamber and Cluster_Paper

SPARCL1 LPP

9.03e-04185112ba5baa4d7f097108622674de5b7f4fd279843d24
ToppCellLV-07._Pericyte|LV / Chamber and Cluster_Paper

SPARCL1 LPP

9.03e-04185112acb38eba871ec72f2a8136a33b87d33b8c85465d
ToppCellCOVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations)

SPARCL1 LPP

9.22e-04187112464a0c3b92b778911b5f9cd73642e09e3472063a
ToppCell10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SPARCL1 NLRP1

9.22e-04187112db771e952f71a12886c2dbc77c6cd07054ef809a
ToppCellControl-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class

TRPM6 SPARCL1

9.22e-041871125429ae85942b8ec3895cceb63c663de3c24ca064
ToppCellPCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung

SPARCL1 LPP

9.32e-0418811274f7d216209cabdc96b2d46685b0ae017fdcc8fc
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SPARCL1 LPP

9.32e-041881124d1e5f85342ae550086609d7680e32730b78b5d2
ToppCellnormal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass

SPARCL1 LPP

9.32e-04188112fd70fb89570f014d1299c60fe017dc09f24e57c6
ToppCell5'-Adult-Appendix-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.42e-041891120daa8efac08dca9525d2b8d421952068cab4eb50
ToppCellPND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass

FANCC SPARCL1

9.42e-04189112dc5164591dea45b420798b94dda211be03daa70c
ToppCell5'-Adult-Appendix-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.42e-04189112b6bb4327b4560d07d2b728abcc5f144f428948a5
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 LPP

9.52e-041901125681c211baeed4af82a2bbc13420f6a7b487581c
ToppCellPND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass

FANCC SPARCL1

9.52e-041901121196b8ea2c44c7c80f5ee589dd517e6a413f2077
ToppCell3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.62e-04191112de2cd94ee88a7754f86d39469e38374d668210c7
ToppCellNS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

DMXL2 MUC5AC

9.62e-04191112769942a6a31c13c583dc38e8a762df2f5c06c2fb
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SPARCL1 LPP

9.62e-04191112d35692c652977500a3c36aa26c347a072b71e441
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SPARCL1 LPP

9.62e-041911122a107e9096eb58b81b3da61547904d85754f6b2f
ToppCellNS-critical-d_16-33-Epithelial-Secretory-diff|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

SPARCL1 MUC5AC

9.72e-0419211202b11233b4da2d85b96498b3c6e22e3a31b3d049
ToppCellP28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPARCL1 LPP

9.72e-0419211287c7780cf72f4c204f2a5f6655309d47a23c08ae
ToppCell5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 NLRP1

9.72e-041921128ad6678df89175c5a4a835c8566f1552df3c996e
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 LPP

9.72e-0419211224e2f15f5767a97eb3b389922bcfd7b13805e1ce
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.72e-04192112d0fb6885f023d55a2b7984c99db9c6463258f788
ToppCellP15-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPARCL1 LPP

9.72e-04192112a476895b7b252c388d6346eacbc72f0115b1443e
ToppCell5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 NLRP1

9.72e-041921122f5378ea0b2fb2f672a36585d375f675983363a1
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 NLRP1

9.72e-04192112c0e59e642b42c055cf73d029cf54d07d9b719359
ToppCell368C-Fibroblasts-Fibroblast-K_(Pericytes)|368C / Donor, Lineage, Cell class and subclass (all cells)

SPARCL1 LPP

9.82e-041931125182284dfa7c94027e94172e08f78c86b95d63f4
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 NLRP1

9.82e-041931122e72309607902dabe3218888b22a77fe941f3570
ToppCell5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.82e-04193112173f1d83133f5ffa88e2a75d28835ad7acd2aa90
ToppCell5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.82e-041931120256e8fe4a47f2e2a43ef9d19bfc047d20806d69
ToppCell3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.82e-04193112b1893193766ae41bf2ab6ed4083285c9c814e608
ToppCellChildren_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor

DMXL2 NLRP1

9.82e-0419311258e1930a1d80ad3729ab9604ac8ebf7308232a3d
ToppCell368C-Fibroblasts-Fibroblast-K_(Pericytes)-|368C / Donor, Lineage, Cell class and subclass (all cells)

SPARCL1 LPP

9.82e-041931124f7bab0115469c855160636d168bd6e5d4e2dd2f
ToppCell5'-Adult-Distal_Rectal-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.82e-041931127631bf3362b4fa061ffeab4879ab12c4708dc4c0
ToppCell3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.82e-04193112a402e736440684ebe123673b6b0c6fcd8fa057b2
ToppCell5'-Adult-Distal_Rectal-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SPARCL1 LPP

9.82e-041931128d15c63f2ae48d0a00d7ef5fdafa917ab8ad0571
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SPARCL1 LPP

9.82e-04193112800b0f5705fefcd3608e37801afae8a94474723e
ToppCellE15.5-Mesenchymal-myocytic_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPARCL1 LPP

9.82e-041931123316d6a39abb6a518d45b846254325fc7a8b2035
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 NLRP1

9.82e-0419311252e918884877b6659cdca0496390e440f73694a9
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SPARCL1 NLRP1

9.82e-04193112287e756d5fd3bd2931c168da24beaa0d02a350ae
ToppCellE15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPARCL1 LPP

9.82e-04193112e787e618f6e8a1e22be366ce606bf78831b60a90
ToppCellP28-Mesenchymal-myocytic_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPARCL1 LPP

9.92e-0419411283e45441c74b7f50b6725876b583229280179dc2
ToppCellP28-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

SPARCL1 LPP

9.92e-041941123c661c6768c3f05d2aba03d329adb257ca201b2d
DrugVincamine [1617-90-9]; Up 200; 11.2uM; PC3; HT_HG-U133A

DMXL2 LPP VPS53 NLRP1

1.58e-061931144341_UP
Drugnarbonolide

MUC5AC NLRP1

5.93e-068112CID005282035
DrugAC1MHXBB

MUC5AC NLRP1

2.22e-0515112CID003034322
Drugambroxol

LPP NLRP1

5.82e-0524112CID000002132
Drugfluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA

DMXL2 MUC5AC VPS53

6.69e-051721131017_UP
Drugglycoprotein

MUC5AC NLRP1

8.55e-0529112CID000439212
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A

MUC5AC NLRP1 WDR47

8.71e-051881133177_UP
Drugbeta-aspartylhydroxamate

TRPM6 NLRP1

9.16e-0530112CID000065274
DrugGlycopyrrolate [596-51-0]; Up 200; 10uM; MCF7; HT_HG-U133A

DMXL2 SPARCL1 MUC5AC

9.56e-051941134709_UP
DrugMethionine sulfoximine (L) [15985-39-4]; Up 200; 22.2uM; PC3; HT_HG-U133A

MUC5AC VPS53 NLRP1

9.70e-051951134070_UP
Drug17-DMAG; Up 200; 0.1uM; HL60; HT_HG-U133A

DMXL2 MUC5AC NLRP1

9.70e-051951136172_UP
DrugCapsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A

TRPM6 VPS53 NLRP1

9.70e-051951135673_UP
DrugAlfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A

LPP VPS53 NLRP1

9.70e-051951133135_DN
DrugFlumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A

DMXL2 VPS53 NLRP1

9.70e-051951134272_UP
DrugDelcorine; Down 200; 8.4uM; PC3; HT_HG-U133A

FANCC LPP VPS53

9.70e-051951133715_DN
DrugCisapride [81098-60-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A

SPARCL1 VPS53 NLRP1

9.85e-051961133305_UP
DrugPNU-0230031 [267429-39-0]; Up 200; 10uM; PC3; HT_HG-U133A

MUC5AC LPP VPS53

9.85e-051961134288_UP
Drug2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; HL60; HT_HG-U133A

SPARCL1 VPS53 NLRP1

1.00e-041971133063_UP
DrugFamotidine [76824-35-6]; Up 200; 11.8uM; PC3; HT_HG-U133A

SPARCL1 VPS53 NLRP1

1.00e-041971136665_UP
DrugDelsoline [509-18-2]; Up 200; 8.6uM; HL60; HT_HG-U133A

LPP VPS53 NLRP1

1.00e-041971132513_UP
DrugNabumetone [42924-53-8]; Up 200; 17.6uM; PC3; HT_HG-U133A

MUC5AC VPS53 NLRP1

1.02e-041981136327_UP
DrugBenzthiazide [91-33-8]; Down 200; 9.2uM; HL60; HT_HG-U133A

DMXL2 LPP NLRP1

1.02e-041981132989_DN
DrugEthotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A

SPARCL1 VPS53 NLRP1

1.02e-041981133809_UP
DrugParomomycin sulfate [1263-89-4]; Down 200; 5.6uM; HL60; HT_HG-U133A

FANCC VPS53 NLRP1

1.03e-041991133017_DN
DrugProxyphylline [603-00-9]; Up 200; 16.8uM; PC3; HT_HG-U133A

LPP VPS53 NLRP1

1.03e-041991137290_UP
DrugTorsemide [56211-40-6]; Up 200; 11.4uM; HL60; HT_HG-U133A

LPP VPS53 NLRP1

1.03e-041991132956_UP
DrugEsculin Hydrate [531-75-9]; Down 200; 11.8uM; HL60; HT_HG-U133A

DMXL2 LPP NLRP1

1.05e-042001133052_DN
DrugS-methylcysteine

FANCC NLRP1

1.18e-0434112CID000024417
Drugcellobiitol

TRPM6 MUC5AC

1.40e-0437112CID000003871
Drugbromide

FANCC MUC5AC NLRP1

2.45e-04267113CID000000259
DrugPHEMA

TRPM6 NLRP1

2.46e-0449112CID000013360
Drugrebamipide

MUC5AC NLRP1

2.67e-0451112CID000005042
DrugD00992

MUC5AC NLRP1

2.78e-0452112CID011954225
DrugKalzinol

LPP NLRP1

5.18e-0471112CID000105003
DrugsLea

MUC5AC NLRP1

6.25e-0478112CID000643993
Drug2-naphthalenesulfonate

FANCC NLRP1

8.67e-0492112CID000008420
DrugAC1NDP1U

FANCC NLRP1

1.35e-03115112CID004629339
DrugPb m

MUC5AC NLRP1

1.42e-03118112CID006327255
Diseaseacute myeloid leukemia (is_implicated_in)

FANCC LPP

4.33e-0484112DOID:9119 (is_implicated_in)
DiseaseInhalant adrenergic use measurement

MUC5AC LPP

5.65e-0496112EFO_0009941
Diseaserespiratory system disease

MUC5AC LPP

1.28e-03145112EFO_0000684
DiseaseLeukemia, Myelocytic, Acute

FANCC LPP

1.82e-03173112C0023467
Diseaseasthma

DMXL2 MUC5AC LPP

2.33e-03751113MONDO_0004979

Protein segments in the cluster

PeptideGeneStartEntry
VSKEFSMHVCIFECE

DMXL2

1096

Q8TDJ6
CFVMREAVTVEIEFC

NLRP1

1116

Q9C000
TAMDQVFHVDCFTCI

LPP

431

Q93052
CVFDRCHMTDLDVVC

MUC5AC

5171

P98088
CHPAIFRVVDEMFRC

FANCC

286

Q00597
TALHQCCIDDFREMV

PPP1R16A

106

Q96I34
RVHCFEEACVMVAEF

WDR47

161

O94967
ECMVHRDCITIFDAD

TRPM6

371

Q9BX84
VPMEHCITRFFEECD

SPARCL1

621

Q14515
CMAERIAVEFCHVTR

VPS53

311

Q5VIR6
KCRICHMDEVTQIFF

ZNFX1

1561

Q9P2E3